2026-09-08 · 📰 News
Why is INDP stock up today?
Indaptus Therapeutics, Inc. Common Stock · INDP · updated 2026-09-08
PRICE$1.85
CHANGE+51.6%
VOLUME8.5M
6-DAY
In plain English
The only news (“Abbott Cooper PLLC Announces Investigation on Behalf of In…”) is stale (82d old) — too old to explain today's move. Likely momentum, not news.
What it means for you
Finished the day strong — closed near its highs on heavy volume. Risk level: elevated.
Source: GlobeNewswire Inc.: Abbott Cooper PLLC Announces Investigation on Behalf of Indaptus Therapeutics, Inc. Stockholders (2026-06-18)
About Indaptus Therapeutics, Inc. Common Stock
Market cap$246.5M
ExchangeXNAS
Employees5
HQNEW YORK, NY
Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be
Get moves like this before the bell
Free daily email — the biggest movers, explained. No spam.
Not financial advice. Educational only. AI-assisted summary — verify against the linked source. Data may be delayed.